Acer Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $24,614,259.

Profit Margin

Acer Therapeutics Inc. (NASDAQ:ACER): Profit margin
2013 1.26M -16.65M -1315.03%
2014 1.27M -15.05M -1183.45%
2015 2.55M -12.01M -470.18%
2016 2.90M -7.98M -274.69%
2017 -246.30K -14.19M 5762.97%
2018 432.11K -21.28M -4924.81%
2019 0 -28.88M
2020 0 -22.89M
2021 1.26M -14.72M -1168.94%
2022 0 -27.86M

ACER Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
01.26M00432.11K-246.30K2.90M2.55M1.27M1.26M
Cost of revenue
0000000000
Gross profit
01.26M00432.11K-246.30K2.90M2.55M1.27M1.26M
Operating exp.
Research and development
11.92M6.50M11.84M13.85M12.45M8.72M6.49M10.03M12.11M9.18M
Selling and marketing
0000000000
Total operating expenses
24.61M17.20M22.80M29.89M21.71M13.94M9.85M14.64M16.33M13.18M
Operating income
-24.61M-15.94M-22.80M-29.89M-21.71M-13.94M-7.99M-12.09M-15.06M-11.92M
Other income (expenses), net
-1.62M574.39K-82.62K479.47K20.55K-246.30K-1.02M74.60K15.62K-2.48M
Income before tax
-26.23M-15.37M-22.88M-29.41M-21.28M-14.19M-7.98M-12.01M-15.05M-16.65M
Income tax expense
1.62M-645.30K11.81K-537.75K-432.11K246.30K1.03M-4.74K4.13K4.73M
Net income
-27.86M-14.72M-22.89M-28.88M-21.28M-14.19M-7.98M-12.01M-15.05M-16.65M
Earnings per share
Basic EPS
-1.77-1.03-2.06-2.86-2.49-3.84-11.72-21.26-39.65-91.56
Diluted EPS
-1.77-1.03-2.06-2.86-2.49-3.84-11.72-21.26-39.65-91.56
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source